| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |